Determination of cellular growth abnormality

Or a code abnormality of a target detecting polypeptide the mRNA measuring unit grows, especially the cancer abnormality, wherein the target polypeptide is a structure; the front end of the DNA replication outset of the resistive for fluid, composite component. Target polypeptide comprising CDC6, MCM2, MCM3, MCM4, MCM5, MCM6 and MCM7. And cancer pre-cell growth abnormality detection sample when the measuring cancer, comprising a teaching structure (biopsy structure test part smear sample), the mammary cover, the colon, the lung, the bladder, the skin, a throat, the esophagus, the bronchial tube, a lymph node and puncturing tract structure (biopsy sample and sample smear) structure; when the measuring blood cancer and certificate sarcoma's metastasis, detection sample includes the battery for urine, and blood serum the clutch information.